Stay updated on Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3 in the page history, signaling a new build of the page. This change reflects an internal update to the page version and does not affect study data or visible content.
    Difference
    0.1%
    Check dated 2026-04-30T16:47:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.2 to the history and removed the earlier v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T10:23:46.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed in the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T17:43:55.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.3 and removes the previous revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:33.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The study record now shows a Completed status with updated Study Status and Recruitment Status, and new References and Contacts/Locations sections have been added. The previous government-funding operating status notice has been removed.
    Difference
    1.0%
    Check dated 2026-02-11T02:13:29.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice and updated the revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T22:53:40.000Z thumbnail image

Stay in the know with updates to Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.